Abstract
Hypotension is a common occurrence during or after percutaneous coronary intervention. There are a multitude of clinical syndromes that can cause hypotension in this setting, which can be divided into the categories of volume depletion, cardiogenic shock, and peripheral vasodilatation. Rapid assessment with a combination of a focused history, examination of haemodynamic and electrocardiographic monitoring, angiographic imaging, and transthoracic echocardiography will provide insight into the aetiology of the hypotension. Appropriate management can be swiftly instituted in the catheterisation laboratory in most instances, avoiding major morbidity and mortality.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mamas MA, Ratib K, Routledge H, Fath-Ordoubadi F, Neyses L, Louvard Y, Fraser DG, Nolan J. Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart. 2012;98:303–1.
Tavakol M, Ashraf S, Brener SJ. Risks and complications of coronary angiography: a comprehensive review. Glob J Health Sci. 2012;4:65–93.
Ellis SG, Bhatt D, Kapadia S, Lee D, Yen M, Whitlow PL. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006;67:541–5.
Trimarchi S, Smith DE, Share D, Jani SM, O’Donnell M, McNamara R, Riba A, Kline-Rogers E, Gurm HS, Moscucci M. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality. JACC Cardiovasc Interv. 2010;3:845–50.
Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, et al. Bleeding in patients undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2009;2:222–9.
Farouque HM, Tremmel JA, Raissi-Shabari F, Aggarwal M, Fearon WF, et al. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol. 2005;45:363–8.
Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119:1211–9.
Hochman J, Sleeper L, Webb J, et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190–2.
Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H, Davidoff R, Boland J, Modur S, Forman R, Hochman JS. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol. 2003;41:1273–9.
Lahm T, McCaslin CA, Wozniak TC, Ghumman W, Fadl YY, Obeidat OS, Schwab K, Meldrum DR. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol. 2010;56:1435–46.
Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II. Circulation. 2008;117:1717–31.
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–34.
Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G, Krakauer J, Rubenfire M, Fleming P, Noon G, Oldham N, Killip T, Kantrowitz A. Intra-aortic balloon couterpulsation in cardiogenic shock – report of a cooperative clinical trial. N Engl J Med. 1973;288:979–84.
Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287–96.
Saia F, Grigioni F, Marzocchi A, Branzi A. Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am Heart J. 2010;160:s16–21.
Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117:686–97.
Chevalier P, Burri H, Fahrat F, Cucherat M, Jegaden O, Obadia JF, Kirkorian G, Touboul P. Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation. Eur J Cardiothorac Surg. 2004;26:330–5.
Lemery R, Smith HC, Giuliani ER, Gersh BJ. Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol. 1992;70:147–51.
Al-Lamee R, Ielasi A, Latib A, Godino C, Ferraro M, Mussardo M, et al. Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation. J Am Coll Cardiol Interv. 2011;4:87–95.
Meguro K, Ohira H, Nishikido T, Fujita M, Chinen T, Kikuchi T, Nakamura K, Keida T. Outcome of prolonged balloon inflation for the management of coronary perforation. J Cardiol. 2013;61:206–9.
Storger H, Ruef J. Closure of guide wire-induced coronary artery perforation with a two-component fibrin glue. Catheter Cardiovasc Interv. 2007;70:237–40.
Oda H, Oda M, Makiyama Y, Kashimura T, Takahashi K, Miida T, Higuma N. Guidewire-induced coronary artery perforation treated with transcatheter delivery of subcutaneous tissue. Catheter Cardiovasc Diagn. 2005;66:369–74.
Pejkovic B, Krajnc I, Anderhuber F, Kosutic D. Anatomical aspects of the arterial blood supply to the sinoatrial and atrioventricular nodes of the human heart. J Int Med Res. 2008;36:691–8.
Steg G, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2012;33:2569–619.
O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practical guidelines. Circulation. 2013;127:529–55.
Landau C, Lange RA, Glamann DB, Willard JE, Hills LD. Vasovagal reactions in the cardiac catheterization laboratory. Am J Cardiol. 1994;73:95–7.
Gueant-Rodriguez R, Romano A, Barbaud A, Brockow K, Gueant J. Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des. 2006;12:3359–72.
Bertrand ME, Esplugas E, Piessens J, Rasch W. Influence of a non-ionic, iso-osmolar contrast medium (iodixanol) versus and ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: a multicenter, randomized, double-blind study. Circulation. 2000;101:131–6.
Nayak KR, White AA, Cavendish JJ, Barker CM, Kandzari DE. Anaphylactoid reactions to radiocontrast agents: prevention and treatment in the cardiac catheterization laboratory. J Invasive Cardiol. 2009;21:548–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag London
About this chapter
Cite this chapter
Kushwaha, V., Blackman, D. (2016). Acute Onset Hypotension. In: Lindsay, A., Chitkara, K., Di Mario, C. (eds) Complications of Percutaneous Coronary Intervention. Springer, London. https://doi.org/10.1007/978-1-4471-4959-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4959-0_14
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4958-3
Online ISBN: 978-1-4471-4959-0
eBook Packages: MedicineMedicine (R0)